Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib

被引：0
|
作者：
Yuko Oya
Tatsuya Yoshida
Kazuhiro Asada
Tetsuya Oguri
Naoki Inui
Sayako Morikawa
Kentaro Ito
Tomoki Kimura
Eiji Kunii
Takashi Matsui
Akihito Kubo
Tatsuo Kato
Takashi Abe
Takeshi Tsuda
Toyoaki Hida
机构：
[1] Aichi Cancer Center Hospital,Department of Thoracic Oncology
[2] National Cancer Center Hospital,Current Address: Department of Thoracic Oncology
[3] Shizuoka General Hospital,Department of Respiratory Medicine
[4] Nagoya City University,Department of Respiratory Medicine, Allergy and Clinical Immunology
[5] Hamamatsu University School of Medicine,Second Division, Department of Internal Medicine
[6] Fujita Health University School of Medicine,Department of Respiratory Medicine
[7] Matsusaka Municipal Hospital,Respiratory Center
[8] Tosei General Hospital,Department of Respiratory Medicine and Allergy
[9] Nagoya City West Medical Center,Department of Respiratory Medicine
[10] Seirei Mikatahara General Hospital,Department of Respiratory Medicine
[11] Aichi Medical University School of Medicine,Division of Respiratory Medicine and Allergology
[12] National Hospital Organization Nagara Medical Center,Department of Respiratory Medicine
[13] Ogaki Municipal Hospital,Department of Respiratory Medicine
[14] Toyama Prefectural Central Hospital,Department of Respiratory Medicine
来源：
BMC Cancer | / 21卷
关键词：
Epidermal growth factor receptor (EGFR); EGFR-tyrosine kinase inhibitor; Non-small cell lung cancer (NSCLC); Afatinib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib
    Oya, Yuko
    Yoshida, Tatsuya
    Asada, Kazuhiro
    Oguri, Tetsuya
    Inui, Naoki
    Morikawa, Sayako
    Ito, Kentaro
    Kimura, Tomoki
    Kunii, Eiji
    Matsui, Takashi
    Kubo, Akihito
    Kato, Tatsuo
    Abe, Takashi
    Tsuda, Takeshi
    Hida, Toyoaki
    BMC CANCER, 2021, 21 (01)
  • [2] Clinical Utility of Liquid Biopsy for Detecting EGFR T790M Mutation Is Very Limited
    Sakamoto, T.
    Yamane, K.
    Tanaka, N.
    Yanai, M.
    Izumi, H.
    Yamaguchi, K.
    Takeda, K.
    Makino, H.
    Igishi, T.
    Yamasaki, A.
    Simizu, E.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2132 - S2132
  • [3] Real Clinical Practice of Using Afatinib Therapy in NSCLC Patients with an Acquired EGFR T790M Mutation
    Miyazaki, Kunihiko
    Tamura, Tomohiro
    Kaburagi, Takayuki
    Saito, Kazuhito
    Inagaki, Masaharu
    Yamashita, Takaaki
    Ichimura, Hideo
    Nawa, Takeshi
    Endo, Takeo
    Hayashihara, Kenji
    Kimura, Masaki
    Kurishima, Koichi
    Nakamura, Hiroyuki
    Furukawa, Kinya
    Kikuchi, Norihiro
    Satoh, Hiroaki
    Hizawa, Nobuyuki
    ANTICANCER RESEARCH, 2018, 38 (09) : 5409 - 5415
  • [4] Low Detection Rate of EGFR Driver and T790M Mutation in Plasma by Cobas v2 After Acquired Resistance to Afatinib
    Yuko, O.
    Yoshida, T.
    Asada, K.
    Oguri, T.
    Inui, N.
    Morikawa, S.
    Ito, K.
    Kimura, T.
    Kunii, E.
    Matsui, T.
    Kubo, A.
    Kato, T.
    Shindo, J.
    Tsuda, T.
    Okuno, M.
    Hida, T.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1073 - S1074
  • [5] Acquired T790M resistance do afatinib in EGFR mutated lung adenocarcinoma
    Miyazaki, Kunihiko
    Sato, Shinya
    Kodama, Takahide
    Satoh, Hiroaki
    Hizawa, Nobuyuki
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2016, 64 (04): : 317 - 318
  • [6] Clinical implications of T790M mutation in patients with acquired resistance to EGFR tyrosine kinase inhibitors
    Sun, Jong-Mu
    Ahn, Myung-Ju
    Choi, Yoon-La
    Ahn, Jin Seok
    Park, Keunchil
    LUNG CANCER, 2013, 82 (02) : 294 - 298
  • [7] Monitoring the EGFR T790M mutation in liquid biopsy in patients with lung cancer
    Cardos, G.
    Motoc, R.
    Leonte, D. G. N.
    Simion, G.
    Gurban, P.
    Iordache, F.
    Iorga, P.
    Apostol, P. P.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 436 - 437
  • [8] Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor
    D Ercan
    K Zejnullahu
    K Yonesaka
    Y Xiao
    M Capelletti
    A Rogers
    E Lifshits
    A Brown
    C Lee
    J G Christensen
    D J Kwiatkowski
    J A Engelman
    P A Jänne
    Oncogene, 2010, 29 : 2346 - 2356
  • [9] Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor
    Ercan, D.
    Zejnullahu, K.
    Yonesaka, K.
    Xiao, Y.
    Capelletti, M.
    Rogers, A.
    Lifshits, E.
    Brown, A.
    Lee, C.
    Christensen, J. G.
    Kwiatkowski, D. J.
    Engelman, J. A.
    Jaenne, P. A.
    ONCOGENE, 2010, 29 (16) : 2346 - 2356
  • [10] The EGFR T790M Mutation in Acquired Resistance to an Irreversible Second-Generation EGFR Inhibitor
    Kim, Youngwook
    Ko, Jeonghun
    Cui, Zhengyun
    Abolhoda, Amir
    Lee, Jeeyun
    Ahn, Jinseok
    Ou, Sai-Hong
    Ahn, Myung-Ju
    Park, Keunchil
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S421 - S421
12345